Ken Griffin’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203K Buy
+15,100
New +$188K ﹤0.01% 12252
2025
Q2
– Sell
-2,700
Closed -$15.1K – 14360
2025
Q1
$15.1K Sell
2,700
-3,700
-58% -$32.4K ﹤0.01% 13335
2024
Q4
$51.6K Buy
6,400
+5,700
+814% +$52.3K ﹤0.01% 12361
2024
Q3
$7.18K Buy
+700
New +$6.92K ﹤0.01% 13379
2024
Q2
– Sell
-7,700
Closed -$106K – 15070
2024
Q1
$106K Buy
+7,700
New +$91.5K ﹤0.01% 11273
2023
Q3
– Sell
-1,800
Closed -$14K – 14859
2023
Q2
$14K Sell
1,800
-5,600
-76% -$31.8K ﹤0.01% 13020
2023
Q1
$42.2K Buy
7,400
+2,600
+54% +$13.6K ﹤0.01% 12377
2022
Q4
$28.3K Sell
4,800
-15,900
-77% -$53.7K ﹤0.01% 12806
2022
Q3
$66K Sell
20,700
-1,700
-8% -$6.81K ﹤0.01% 11426
2022
Q2
$100K Buy
+22,400
New +$89.4K ﹤0.01% 11414

Other funds holding ORIC

Ken Griffin's ORIC Position: Q3 2026 in Review

Ken Griffin reduced its Oric Pharmaceuticals (ORIC) stake by 19% in Q3 2026, selling an estimated $6.03M and leaving 2,111,325 shares worth $28.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

Ken Griffin first reported a position in ORIC in Q2 2020 and has held it in 21 quarters since. The position peaked at $30.7M in Q1 2026. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Ken Griffin held 2,111,325 shares of Oric Pharmaceuticals worth $28.4M as of Q3 2026.
  • Ken Griffin sold 483,974 Oric Pharmaceuticals shares in Q3 2026, an estimated $6.03M.
  • Oric Pharmaceuticals made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2175 holding.
  • Ken Griffin first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • Ken Griffin's Oric Pharmaceuticals position peaked at $30.7M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.